OSI-930

· Astellas Pharma Inc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OSI-930, covering 2011-09-27 to 2011-09-27. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of OSI-930 in Cancer Patients [Phase 1]